Study: J&J Vaccine 66% Effective Against COVID-19
3 years ago
1.07K
Right now the Johnson and Johnson COVID-19 vaccine is on pause in the U.S. because of concerns over a possible link to rare cases of blood clots.
Loading 5 comments...
-
3:20
Newsy
1 year agoRussia suspends only remaining major nuclear treaty with US
3.49K6 -
2:15
Newsy
3 years agoStudy: J&J COVID-19 Vaccine 72% Effective in U.S.
1.23K4 -
3:23
WXYZ
3 years agoAstraZeneca vaccine is 79% effective against symptomatic Covid-19, company says
52 -
2:08
Reuters
3 years agoJ&J COVID-19 vaccine 66% effective globally
6046 -
3:05
WXYZ
3 years agoPfizer-BioNTech vaccine just as effective against viral variant, study says
223 -
2:40
KJRH
3 years agoPfizer announces COVID-19 vaccine effective among younger population
2983 -
2:00
WCPO
3 years agoPfizer: COVID-19 vaccine 90% effective
2.73K15 -
1:26
KMTV
3 years agoCOVID-19 vaccine looking 90% effective
1111 -
1:01
New York Post
3 years agoHerpes infection possibly linked to COVID-19 vaccine, study says
4.63K29 -
0:21
KTNV
3 years agoStudy: COVID vaccines effective against variants
6.14K8
